Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model.
(2026 May 18)
JAMA
Zahed H, Feng X, Alcala K, Smith-Byrne K, Moez E, Guida F, Albanes D, Weinstein SJ, Arslan AA, Cai Q, Shu XO, Zheng W, Chen C, Triplette M, Tinker LF, Langhammer A, Nøst TH, Hveem K, Milne RL, Bassett JK, Sheikh M, Malekzadeh R, Wang Y, Patel AV, Visvanathan K, Yuan JM, Wang R, Koh WP, Sesso HD, Zhang X, Johansson MB, Amos C, Hung RJ, Muller D, Robbins HA, Johansson M

The signaling upstream of DOT1L-mediated H3K79 methylation.
(2026 May 4)
Epigenomics
Chen C, Wu D, Lv C, Zhu P, Chen Z, Li Q, Li J, Yang J, Zhang J

Gut microbiome in sepsis: from dysbiotic biomarker to precision and palliative decision-making.
(2026)
Front Med (Lausanne) 13(): 1811304
Wang LM, Chen C, Danzheng JC, Zhao J

Research progress on PANoptosis in diabetic cardiomyopathy.
(2026 Apr 28)
J Physiol Biochem 82(1):
Chen C, Lv C, Zhu P, Chen Z, Yang J, Zhang J

ALDH2 inhibits FASN stabilization via the E3 ligase CBL to suppress lipid accumulation and liver cancer development.
(2026 Apr 27)
Biol Direct
Wang Y, Li L, Qu F, Hua T, Chen C, Yang L, Jiang R, Liu X, Cheng P, Min H, Wang Y, Pan X, Sun D, Tang R, Liu R, You H, Kong F